Prof Sanjay Kumar

Novel salts, crystalline forms and premix of hypolipidemic agent.,

Rajiv Sharma; Sanjay Kumar, Brijesh Kumar Srivastava.

Heterocyclic compounds useful as antibacterial agents.

Rajiv Sharma; Pravin Iyer; Jigar Desai; Sanjay Kumar.

Novel substituted ureas as RORγ modulators

Rajiv Sharma; Sanjay Kumar; Brijesh Kumar Srivastava

Novel salts, crystalline forms and premix of hypolipidemic agent.,

Rajiv Sharma; Sanjay Kumar, Brijesh Kumar Srivastava.

Heterocyclic compounds useful as antibacterial agents.

Rajiv Sharma; Pravin Iyer; Jigar Desai; Sanjay Kumar.

Novel substituted ureas as RORγ modulators

Rajiv Sharma; Sanjay Kumar; Brijesh Kumar Srivastava

Cyclopropyl derivatives as ROR modulators.

Ranjit Desai, Sanjay Kumar, Vrajesh Pandya, Jigar Desai, Saurin Raval

Polycyclic compounds as ROR modulators.

Ranjit Desai, Sanjay Kumar, Vrajesh Pandya, Jigar Desai, Saurin Raval.

Novel pyrazolone derivatives for Anemia

Ranjit Desai, Sanjay Kumar, Vrajesh Pandya, Brijesh Darji.

Isotopically marked quinolone derivatives as a HIF-PHD inhibitors.

Ranjit Desai, Sanjay Kumar, Vrajesh Pandya.

Novel compounds as ROR gamma modulators;

Ranjit Desai, Sanjay Kumar, Jigar Desai, Vrajesh Pandya.

Novel salt of topoisomerase inhibitors.

Rajiv Sharma; Sanjay Kumar, Jigar Desai.

Novel oxoindoline compounds as RORg modulators.

Ranjit Desai, Sanjay Kumar, Jigar Desai, Saurin Raval, Vrajesh Pandya.

Novel heterocyclic compounds.

Ranjit Desai, Sanjay Kumar, Jigar Desai, Saurin Raval, Vrajesh Pandya.

Novel compounds suitable for the treatment of dyslipidemia.

Sharma Rajiv, Kumar Sanjay, Pingali Harikishore, Makadia Pankaj, Zaware Pandurang, Pola Suresh, Deshmukh Prashant, Shah Kiran.

Novel hetrocyclic compounds.

Sharma Rajiv, Kumar Sanjay, Srivastava Brijesh, Patel Gautam, Gite Sanjay, Patel Sandip.

Inhibitors of low molecular weight protein tyrosine phosphatase for management of metabolic disorder.

Sharma Rajiv, Kumar Sanjay, Srivastava Brijesh, Gite Sanjay, Shedage Sandeep, Kadam Pravin, Dholakia Parind.

Fused heterocyclic compounds as gpr120 agonists.

Kumar Sanjay, Sharma Rajiv, Sawargave Sangmeshwar, Mahajan Vishal;

Substituted alkyl carboxylic acid derivatives as gpr agonists.

Sharma Rajiv, Halder Somnath, Kumar Sanjay;

Substituted heterocyclic derivatives as GPCR agonists and uses thereof.

Rajiv Sharma, Somnath Halder, Sanjay Kumar, Malcolm Mascarenhas.

Imidazo[4,5-c]quinoline derivatives and uses thereof.

Kumar Sanjay; Sharma Rajiv, Deore Vijaykumar, Yewalkar Nilambari.

Compounds for use as GPR120 agonists.

Sanjay Kumar, Rajiv Sharma, Somnath Halder and Sangameshwar Sawargave.

Phenyl alkanoic acid derivatives as gpr40 agonists.

Sanjay Kumar & Rajiv Sharma, Vishal A. MAHAJAN and Sangameshwar P.

Substituted phenyl alkanoic acid compounds as gpr120 agonists and uses thereof.

Kumar Sanjay, Sharma Rajiv, Deore Vijaykumar, Yewalkar Nilambari.

Compounds containing carbon-carbon linker as gpr120 agonists.

Sharma Rajiv, Kumar Sanjay, Mahajan Vishal, Bajaj Komal, Godse Pallavi.

“Imidazo [4,5-C] quinoline derivatives and their use in the treatment of tumors and/or inflammation”

Sanjay Kumar, Ram Vishwakarma, Ramswaroop Mundada, Vijaykumar Deore, Pramod Kumar, Somesh Sharma,

“Imidazoquinoline Derivatives as Kinase Inhibitors.

Sanjay Kumar, Rajiv Sharma, Rabert, Bichismita Sahu, Veena Agarwal, Nishigandha Naik.

“Imidazopyridine Derivatives”.

Sanjay Kumar, H. Sivaramakrishnan, Mandar Bhonde, Nilesh Dagia, Rajiv Sharma, Pallavi Mane, Pramod Kumar

“Pyridyl derivatives, their preparation and use”

Sanjay Kumar, Vijaykumar Deore, Nilambari Yewalkar, Kalpana Joshi, Magie Rathos, Amol P, Mandar Bhonde,

Substituted Imidazoquinoline Derivatives.

Sanjay Kumar, Rajiv Sharma, Vijaykumar Deore, Nilambari Yewalkar, Veena Agarwal, Nilesh Dagia, Nishigandha Naik.